tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Bing Zhao, 1 are a BUY (100%).
Analyst Bing Zhao, currently employed at CHINA RENAISSANCE, carries an average stock price target met ratio of 100% that have a potential upside of 88.55% achieved within 201 days. Previously, Bing Zhao worked at STIFEL.
Bing Zhao’s has documented 3 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IMAB, I-Mab at 08-Jul-2021.
Analyst best performing recommendations are on IMAB (I-MAB).
The best stock recommendation documented was for IMAB (I-MAB) at 2/11/2020. The price target of $18 was fulfilled within 78 days with a profit of $6.82 (61%) receiving and performance score of 7.82.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2025
$9
$5.02 (126.13%)
$9
11 months 5 days ago
(24-Oct-2025)
0/3 (0%)
$4.78 (113.27%)
Buy Since 02-Nov-2021
$6
$2.02 (50.75%)
$6
1 years 21 days ago
(08-Sep-2025)
4/8 (50%)
$1.73 (40.52%)
44
Buy Since 28-Aug-2025
$8
$4.02 (101.01%)
1 years 1 months 1 days ago
(28-Aug-2025)
0/1 (0%)
$3.75 (88.24%)
Buy Since 03-Mar-2021
$7
1 years 1 months 8 days ago
(21-Aug-2025)
1/6 (16.67%)
$4.43 (172.37%)
85
Buy Since 09-Jul-2025
$7
$3.02 (75.88%)
$7
1 years 1 months 8 days ago
(21-Aug-2025)
0/2 (0%)
$2.29 (48.62%)
What Year was the first public recommendation made by Bing Zhao?
